The chemokine receptor CXCR7 has emerged as a regulator of prostate tumor growth and invasion, along with the well-established role of its closely related receptor, CXCR4, and their shared ligand, SDF-1α. Consequently, inhibition of the CXCR7/CXCR4/SDF-1α axis may assist in controlling prostate tumor growth and progression. To facilitate the development of potential therapeutics, further clarification of CXCR7 function is required, specifically in relation to CXCR4. In this study, we report that CXCR7 and CXCR4 were co-expressed in LNCaP, DU145 and PC3 cell lines in 2D culture. When cultured in 3D using Matrigel, a marked up-regulation of both receptors was observed in PC3 cells. Interestingly, both CXCR7 and CXCR4 co-localized within ra...
Prostate and breast cancers are among the most frequently diagnosed malignancies in the United State...
Human prostate cancers (PCa) express great variability in their ability to metastasize to bone. The ...
Recent advances have revealed a significant contribution of chemokines and their receptors in tumor ...
CXCR7 was recently identified as the second member of the chemokine receptor family to bind stromal ...
The mechanisms leading to prostate cancer metas-tasis are not understood completely. Although there ...
AbstractThe mechanisms leading to prostate cancer metastasis are not understood completely. Although...
BackgroundIdentifying cellular signaling pathways that become corrupted in the presence of androgens...
Background The cellular and molecular mechanisms that mediate interactions between tumour cells and...
Development of cholangiocarcinoma (CCA) is dependent on a cross-talk with stromal cells, which relea...
The mechanisms by which prostate cancer (PCa) cell adhesion and migration are controlled during meta...
The atypical C-X-C chemokine receptor 7 (CXCR7) is implicated in supporting aggressive cancer phenot...
Background\ud Carcinoma cells must circumvent the normally suppressive signals to disseminate. While...
The receptor (CXCR4) for the stromal-derived factor-1 (SDF1) and the urokinase-receptor (uPAR) are u...
This project investigates effects of flow and CXC chemokine ligand-12, CXCL12 stimuli on prostate ca...
The receptor (CXCR4) for the stromal-derived factor-1 (SDF1) and the urokinase-receptor (uPAR) are u...
Prostate and breast cancers are among the most frequently diagnosed malignancies in the United State...
Human prostate cancers (PCa) express great variability in their ability to metastasize to bone. The ...
Recent advances have revealed a significant contribution of chemokines and their receptors in tumor ...
CXCR7 was recently identified as the second member of the chemokine receptor family to bind stromal ...
The mechanisms leading to prostate cancer metas-tasis are not understood completely. Although there ...
AbstractThe mechanisms leading to prostate cancer metastasis are not understood completely. Although...
BackgroundIdentifying cellular signaling pathways that become corrupted in the presence of androgens...
Background The cellular and molecular mechanisms that mediate interactions between tumour cells and...
Development of cholangiocarcinoma (CCA) is dependent on a cross-talk with stromal cells, which relea...
The mechanisms by which prostate cancer (PCa) cell adhesion and migration are controlled during meta...
The atypical C-X-C chemokine receptor 7 (CXCR7) is implicated in supporting aggressive cancer phenot...
Background\ud Carcinoma cells must circumvent the normally suppressive signals to disseminate. While...
The receptor (CXCR4) for the stromal-derived factor-1 (SDF1) and the urokinase-receptor (uPAR) are u...
This project investigates effects of flow and CXC chemokine ligand-12, CXCL12 stimuli on prostate ca...
The receptor (CXCR4) for the stromal-derived factor-1 (SDF1) and the urokinase-receptor (uPAR) are u...
Prostate and breast cancers are among the most frequently diagnosed malignancies in the United State...
Human prostate cancers (PCa) express great variability in their ability to metastasize to bone. The ...
Recent advances have revealed a significant contribution of chemokines and their receptors in tumor ...